MAYBAKER Stock Overview
May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
May & Baker Nigeria plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₦6.60 |
| 52 Week High | ₦8.50 |
| 52 Week Low | ₦3.90 |
| Beta | 0.010 |
| 1 Month Change | -0.60% |
| 3 Month Change | -6.25% |
| 1 Year Change | 48.31% |
| 3 Year Change | 43.48% |
| 5 Year Change | 186.96% |
| Change since IPO | 392.80% |
Recent News & Updates
Recent updates
Shareholder Returns
| MAYBAKER | NG Pharmaceuticals | NG Market | |
|---|---|---|---|
| 7D | 10.0% | 1.0% | 1.1% |
| 1Y | 48.3% | 22.2% | 123.0% |
Return vs Industry: MAYBAKER exceeded the NG Pharmaceuticals industry which returned 18% over the past year.
Return vs Market: MAYBAKER underperformed the NG Market which returned 120.7% over the past year.
Price Volatility
| MAYBAKER volatility | |
|---|---|
| MAYBAKER Average Weekly Movement | 9.8% |
| Pharmaceuticals Industry Average Movement | 3.7% |
| Market Average Movement | 7.9% |
| 10% most volatile stocks in NG Market | 11.1% |
| 10% least volatile stocks in NG Market | 3.5% |
Stable Share Price: MAYBAKER has not had significant price volatility in the past 3 months.
Volatility Over Time: MAYBAKER's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of NG stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1944 | 364 | Patrick Ajah | may-baker.com |
May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria. It operates through Pharmaceuticals and Beverage segments. The company offers pharmaceuticals, including anti-diabetic, anti-hypersensitive, anti-infective, anti-malaria, analgesic, cough and cold, and anxiolytics; and nature care products.
May & Baker Nigeria plc Fundamentals Summary
| MAYBAKER fundamental statistics | |
|---|---|
| Market cap | ₦11.39b |
| Earnings (TTM) | ₦1.45b |
| Revenue (TTM) | ₦21.87b |
7.8x
P/E Ratio0.5x
P/S RatioIs MAYBAKER overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MAYBAKER income statement (TTM) | |
|---|---|
| Revenue | ₦21.87b |
| Cost of Revenue | ₦14.25b |
| Gross Profit | ₦7.62b |
| Other Expenses | ₦6.16b |
| Earnings | ₦1.45b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.84 |
| Gross Margin | 34.83% |
| Net Profit Margin | 6.65% |
| Debt/Equity Ratio | 66.9% |
How did MAYBAKER perform over the long term?
See historical performance and comparisonDividends
4.5%
Current Dividend Yield67%
Payout RatioDoes MAYBAKER pay a reliable dividends?
See MAYBAKER dividend history and benchmarks| May & Baker Nigeria dividend dates | |
|---|---|
| Ex Dividend Date | May 22 2024 |
| Dividend Pay Date | Jun 06 2024 |
| Days until Ex dividend | 12 days |
| Days until Dividend pay date | 27 days |
Does MAYBAKER pay a reliable dividends?
See MAYBAKER dividend history and benchmarks